Free Trial

Meihua International Medical Technologies (MHUA) Competitors

Meihua International Medical Technologies logo
$0.38 -0.01 (-2.21%)
Closing price 03:59 PM Eastern
Extended Trading
$0.39 +0.01 (+2.08%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MHUA vs. EDAP, QTI, ECOR, APT, INO, MLSS, DXR, TMDIF, NMTC, and NEPH

Should you be buying Meihua International Medical Technologies stock or one of its competitors? The main competitors of Meihua International Medical Technologies include Edap Tms (EDAP), QT Imaging (QTI), electroCore (ECOR), Alpha Pro Tech (APT), Inovio Pharmaceuticals (INO), Milestone Scientific (MLSS), Daxor (DXR), Titan Medical (TMDIF), NeuroOne Medical Technologies (NMTC), and Nephros (NEPH). These companies are all part of the "medical equipment" industry.

Meihua International Medical Technologies vs. Its Competitors

EDAP TMS (NASDAQ:EDAP) and Meihua International Medical Technologies (NASDAQ:MHUA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

62.7% of EDAP TMS shares are held by institutional investors. Comparatively, 1.2% of Meihua International Medical Technologies shares are held by institutional investors. 0.2% of EDAP TMS shares are held by insiders. Comparatively, 66.6% of Meihua International Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, EDAP TMS and EDAP TMS both had 1 articles in the media. EDAP TMS's average media sentiment score of 1.87 beat Meihua International Medical Technologies' score of 0.79 indicating that EDAP TMS is being referred to more favorably in the media.

Company Overall Sentiment
EDAP TMS Very Positive
Meihua International Medical Technologies Positive

EDAP TMS presently has a consensus target price of $8.50, indicating a potential upside of 507.14%. Given EDAP TMS's stronger consensus rating and higher possible upside, research analysts clearly believe EDAP TMS is more favorable than Meihua International Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EDAP TMS
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Meihua International Medical Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Meihua International Medical Technologies has a net margin of 0.00% compared to EDAP TMS's net margin of -34.45%. Meihua International Medical Technologies' return on equity of 0.00% beat EDAP TMS's return on equity.

Company Net Margins Return on Equity Return on Assets
EDAP TMS-34.45% -51.42% -26.43%
Meihua International Medical Technologies N/A N/A N/A

Meihua International Medical Technologies has higher revenue and earnings than EDAP TMS.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EDAP TMS$69.18M0.76-$20.58M-$0.62-2.26
Meihua International Medical Technologies$96.90M0.13$10.84MN/AN/A

Summary

EDAP TMS and Meihua International Medical Technologies tied by winning 6 of the 12 factors compared between the two stocks.

Get Meihua International Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MHUA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MHUA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MHUA vs. The Competition

MetricMeihua International Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$12.40M$10.55B$5.70B$9.51B
Dividend YieldN/A2.00%4.69%4.01%
P/E RatioN/A17.0728.0720.05
Price / Sales0.1329.18448.5799.42
Price / Cash0.8623.0336.2258.56
Price / Book0.063.698.665.87
Net Income$10.84M$234.77M$3.25B$258.55M
7 Day Performance-15.51%6.32%4.20%2.23%
1 Month Performance-8.41%8.39%10.82%12.76%
1 Year Performance-62.74%-13.51%34.70%19.36%

Meihua International Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MHUA
Meihua International Medical Technologies
0.9642 of 5 stars
$0.38
-2.2%
N/A-62.3%$12.40M$96.90M0.00620High Trading Volume
EDAP
Edap Tms
3.0714 of 5 stars
$1.51
-0.7%
$8.50
+462.9%
-70.2%$56.84M$69.18M-2.44230Positive News
QTI
QT Imaging
N/A$2.08
+2.5%
N/A+189.9%$56.44M$4.00M0.00N/A
ECOR
electroCore
3.2769 of 5 stars
$7.10
-2.3%
$25.50
+259.2%
+21.5%$54.28M$25.18M-4.5550Positive News
APT
Alpha Pro Tech
1.1191 of 5 stars
$4.74
-0.2%
N/A-18.2%$51.50M$58.18M12.81120
INO
Inovio Pharmaceuticals
4.005 of 5 stars
$1.42
+2.2%
$8.80
+519.7%
-86.1%$50.98M$220K-0.45320High Trading Volume
MLSS
Milestone Scientific
2.7646 of 5 stars
$0.63
+1.9%
$1.25
+98.4%
-38.7%$49.44M$8.61M-9.0030Negative News
DXR
Daxor
3.9715 of 5 stars
$9.18
+2.0%
$25.00
+172.3%
+5.8%$43.53MN/A0.0037
TMDIF
Titan Medical
N/A$0.38
+2.8%
N/A+979.5%$43.37M$17.63M-0.3050Gap Down
NMTC
NeuroOne Medical Technologies
2.7616 of 5 stars
$0.90
+5.5%
$1.45
+61.1%
+11.1%$42.50M$3.45M-4.0920High Trading Volume
NEPH
Nephros
3.226 of 5 stars
$3.57
-1.9%
$5.00
+40.1%
+56.4%$38.64M$14.16M51.0130Positive News

Related Companies and Tools


This page (NASDAQ:MHUA) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners